Table 1.
Individuals’ characteristics
| Variables | Total (N = 996) | HIV negative (n = 768) | HIV positive (n = 228) | P-value |
|---|---|---|---|---|
| Age (years), median (IQR) | 41.3 (30.4–54.8) | 43.7 (30.3–58.5) | 35.1 (30.4–42.6) | <0.001 |
| Sex: male (n)* | 593 (60.1) | 430 (56.7) | 163 (71.5) | <0.001 |
| Weight (kg), median (IQR) | 51.2 (45.8–58.9) | 52 (46.0–59.3) | 50 (43.7–57.2) | 0.009 |
| Type of TB | 0.36 | |||
| Pulmonary | 744 (74.7) | 579 (75.4) | 165 (72.4) | |
| Extrapulmonary | 252 (25.3) | 189 (24.6) | 63 (27.6) | |
| Prior TB diagnosis | 189 (18.9) | 121 (15.6) | 68 (29.8) | <0.001 |
| Culture results | 0.12 | |||
| Not done | 449 (45.1) | 350 (45.6) | 99 (43.4) | |
| Negative | 138 (13.8) | 97 (12.6) | 41 (18) | |
| Positive | 409 (41.1) | 323 (41.8) | 88 (38.6) | |
| Smear results | 0.05 | |||
| Not done | 112 (11.2) | 88 (11.5) | 24 (10.5) | |
| Negative | 490 (49.2) | 362 (47.1) | 128 (56.1) | |
| Positive | 394 (39.6) | 320 (41.4) | 76 (33.3) | |
| Drug resistance profile | 0.66 | |||
| No resistance | 224 (72.7) | 167 (72.3) | 57 (74) | |
| Mono resistance | 50 (16.2) | 38 (16.5) | 12 (15.6) | |
| Polyresistance | 15 (4.9) | 13 (5.6) | 2 (2.6) | |
| Multidrug resistant | 19 (6.2) | 13 (5.6) | 6 (7.8) | |
| Diabetes | 81 (8.1) | 77 (10) | 4 (1.8) | <0.001 |
| Chronic kidney disease | 19 (1.9) | 16 (2.1) | 3 (1.3) | 0.46 |
| CD4 cell count (cells/mm3), median (IQR) | 74 (27–199) |
IQR: interquartile range; TB: tuberculosis.
*
Data are n (%) unless otherwise specified.